http://www.prnewswire.com/rss/health/clinical-trials-medial-discoveries-news.rss/ Press Releases from PR Newswire about Clinical Trials & Medical Discoveries en-us Thu, 03 Jan 2013 05:33:41 EST Thu, 03 Jan 2013 05:00:00 EST http://www.prnewswire.com/news-releases/trovagene-to-study-transrenal-braf-mutations-in-primary-and-metastatic-cancers-185515342.html http://www.prnewswire.com/news-releases/trovagene-to-study-transrenal-braf-mutations-in-primary-and-metastatic-cancers-185515342.html Thu, 03 Jan 2013 05:00:00 EST SAN DIEGO, Jan. 3, 2013 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a developer of transrenal molecular diagnostics, announced that it has entered into a clinical collaboration with The University of Texas MD Anderson Cancer Center to detect transrenal BRAF...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/amakem-secures-14m-grant-to-apply-its-localized-drug-action-technology-in-inflammatory-bowel-diseases-ibd-185513242.html http://www.prnewswire.com/news-releases/amakem-secures-14m-grant-to-apply-its-localized-drug-action-technology-in-inflammatory-bowel-diseases-ibd-185513242.html Thu, 03 Jan 2013 04:15:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/phase-3-decision-trial-of-nexavar-sorafenib-meets-primary-endpoint-of-improving-progression-free-survival-in-patients-with-radioactive-iodine-refractory-differentiated-thyroid-cancer-185510462.html http://www.prnewswire.com/news-releases/phase-3-decision-trial-of-nexavar-sorafenib-meets-primary-endpoint-of-improving-progression-free-survival-in-patients-with-radioactive-iodine-refractory-differentiated-thyroid-cancer-185510462.html Thu, 03 Jan 2013 02:30:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/kareus-therapeutics-announces-phase-i-trial-for-product-in-alzheimers-disease-185509812.html http://www.prnewswire.com/news-releases/kareus-therapeutics-announces-phase-i-trial-for-product-in-alzheimers-disease-185509812.html Thu, 03 Jan 2013 02:00:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/epirus-biopharmaceuticals-inc-announces-positive-phase-1-data-for-bow-015-185498622.html http://www.prnewswire.com/news-releases/epirus-biopharmaceuticals-inc-announces-positive-phase-1-data-for-bow-015-185498622.html Wed, 02 Jan 2013 23:34:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/dr-farzan-filsoufi-advises-new-heart-study-shows-diabetic-patients-with-multiple-blockages-live-longer-with-bypass-surgery-than-stents-185455652.html http://www.prnewswire.com/news-releases/dr-farzan-filsoufi-advises-new-heart-study-shows-diabetic-patients-with-multiple-blockages-live-longer-with-bypass-surgery-than-stents-185455652.html Wed, 02 Jan 2013 15:47:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/breakthrough-research-in-dna-mutation-analysis-could-lead-to-earlier-diagnosis-and-more-tools-for-personalized-treatment-for-cancer-patients-185435562.html http://www.prnewswire.com/news-releases/breakthrough-research-in-dna-mutation-analysis-could-lead-to-earlier-diagnosis-and-more-tools-for-personalized-treatment-for-cancer-patients-185435562.html Wed, 02 Jan 2013 12:39:00 EST WASHINGTON, Jan. 2, 2013 /PRNewswire/ -- New research appearing online today in Clinical Chemistry, the journal of AACC, shows that the analysis of DNA mutations in patients with cancer can be done without surgery. This paper by Chan et al. shows that the plasma of cancer patients...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/saint-lukes-seeks-qualified-applicants-for-cardiovascular-outcomes-fellowships-185424072.html http://www.prnewswire.com/news-releases/saint-lukes-seeks-qualified-applicants-for-cardiovascular-outcomes-fellowships-185424072.html Wed, 02 Jan 2013 11:00:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/adrenomed-ag-develops-new-drug-to-reduce-mortality-from-septic-shock-185421832.html http://www.prnewswire.com/news-releases/adrenomed-ag-develops-new-drug-to-reduce-mortality-from-septic-shock-185421832.html Wed, 02 Jan 2013 10:38:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/sphingotec-announces-launch-of-blood-test-for-breast-cancer-prediction-185419482.html http://www.prnewswire.com/news-releases/sphingotec-announces-launch-of-blood-test-for-breast-cancer-prediction-185419482.html Wed, 02 Jan 2013 10:18:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/waismann-method-medical-director-expresses-concern-about-shift-in-opioid-drug-use-185418022.html http://www.prnewswire.com/news-releases/waismann-method-medical-director-expresses-concern-about-shift-in-opioid-drug-use-185418022.html Wed, 02 Jan 2013 10:03:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/new-swiss-study-adds-more-evidence-for-treating-ptsd-with-mdma-assisted-psychotherapy-185411432.html http://www.prnewswire.com/news-releases/new-swiss-study-adds-more-evidence-for-treating-ptsd-with-mdma-assisted-psychotherapy-185411432.html Wed, 02 Jan 2013 09:00:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/fda-grants-accelerated-approval-for-sirturo-bedaquiline-as-part-of-combination-therapy-to-treat-adults-with-pulmonary-multi-drug-resistant-tuberculosis-185280392.html http://www.prnewswire.com/news-releases/fda-grants-accelerated-approval-for-sirturo-bedaquiline-as-part-of-combination-therapy-to-treat-adults-with-pulmonary-multi-drug-resistant-tuberculosis-185280392.html Mon, 31 Dec 2012 09:00:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/aeterna-zentaris-granted-special-protocol-assessment-by-the-fda-for-phase-3-registration-trial-in-endometrial-cancer-with-aezs-108-185036111.html http://www.prnewswire.com/news-releases/aeterna-zentaris-granted-special-protocol-assessment-by-the-fda-for-phase-3-registration-trial-in-endometrial-cancer-with-aezs-108-185036111.html Fri, 28 Dec 2012 07:30:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/omeros-reports-oms103hp-phase-3-clinical-trial-results-184970131.html http://www.prnewswire.com/news-releases/omeros-reports-oms103hp-phase-3-clinical-trial-results-184970131.html Thu, 27 Dec 2012 16:00:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/ohr-pharmaceutical-provides-update-to-shareholders-on-2012-accomplishments-and-milestones-for-2013-184926371.html http://www.prnewswire.com/news-releases/ohr-pharmaceutical-provides-update-to-shareholders-on-2012-accomplishments-and-milestones-for-2013-184926371.html Thu, 27 Dec 2012 09:15:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/new-category-i-cpt-codes-and-payment-rates-for-circulating-tumor-cell-testing-effective-january-1-184920021.html http://www.prnewswire.com/news-releases/new-category-i-cpt-codes-and-payment-rates-for-circulating-tumor-cell-testing-effective-january-1-184920021.html Thu, 27 Dec 2012 08:00:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/gobalto-raises-12-million-in-series-b-financing-from-edbi-and-qualcomm-ventures-184919661.html http://www.prnewswire.com/news-releases/gobalto-raises-12-million-in-series-b-financing-from-edbi-and-qualcomm-ventures-184919661.html Thu, 27 Dec 2012 08:00:00 EST en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/us-food-and-drug-administration-accepts-xiaflex-supplemental-biologics-license-application-filing-for-the-treatment-of-peyronies-disease-184915821.html http://www.prnewswire.com/news-releases/us-food-and-drug-administration-accepts-xiaflex-supplemental-biologics-license-application-filing-for-the-treatment-of-peyronies-disease-184915821.html Thu, 27 Dec 2012 07:00:00 EST MALVERN, Pa., Dec. 27, 2012 /PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and granted standard review status to its supplemental Biologics...

]]>

]]> PRNewswire en-US PR Newswire Association LLC. http://www.prnewswire.com/news-releases/prionics-evaluacion-favorable-en-europa-del-test-de-la-tuberculosis-bovigam-184894711.html http://www.prnewswire.com/news-releases/prionics-evaluacion-favorable-en-europa-del-test-de-la-tuberculosis-bovigam-184894711.html Thu, 27 Dec 2012 02:30:00 EST es PR Newswire Association LLC.